Literature DB >> 17689343

Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?

Allison M Salmon1, Hla-Hla Thein, Jo Kimber, John M Kaldor, Lisa Maher.   

Abstract

BACKGROUND AND OBJECTIVES: There is currently limited evidence on medium to long term community perceptions of public amenity where supervised injecting centres operate (SIC). Our objective was to investigate if community perceptions of public amenity have changed over time, comparing data collected prior to the establishment of the Sydney Medically Supervised Injecting Centre (MSIC), after 18 months and then following four and a half years of operation.
METHODS: Telephone surveys were conducted among random samples of local residents and business operators in the vicinity of the MSIC at baseline, in the short term (following 18 months of operation) and in the medium term (following four and a half years of operation). Respondents were asked about their perceptions of drug use and its consequences in their neighbourhood, and to describe what they saw as advantages and disadvantages of the Sydney MSIC. Responses were compared over time and according to demographic characteristics of the survey participants.
RESULTS: The survey was completed by 515, 540 and 316 residents and 269, 207 and 210 businesses in the 3 years respectively, with response rates generally above 75%. There was a significant decrease in the proportion of residents and business operators who reported having witnessed public injecting and publicly discarded injecting equipment, in the last month, with no significant change in proportions offered drugs for purchase. Residents were less likely to have seen public injecting in the last month if they were female, retired, lived over 500m from the MSIC or participated in the survey in 2005. Business operators who had witnessed public injecting or discarded needles and syringes in the last month were less likely to report either if located over 500m from the MSIC. Those businesses operating for over 5 years were more likely to have seen publicly discarded needles and syringes than those who had opened within the last year. Approximately 90% of both samples reported at least one advantage of the MSIC located in their area, citing the control of HIV/AIDS and hepatitis C and reduced overdose risk for injecting drug users among potential advantages.
CONCLUSION: While the Sydney MSIC continues to attract political controversy, local residents and business operators perceived significant improvements in public amenity indicators since the opening of the service. Community members appear to be cognizant of both public health (potential reduction in blood borne virus transmission and overdose among injecting drug users) and public amenity benefits of the service.

Entities:  

Mesh:

Year:  2007        PMID: 17689343     DOI: 10.1016/j.drugpo.2006.11.010

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  19 in total

1.  The law (and politics) of safe injection facilities in the United States.

Authors:  Leo Beletsky; Corey S Davis; Evan Anderson; Scott Burris
Journal:  Am J Public Health       Date:  2008-01-02       Impact factor: 9.308

Review 2.  Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: a Systematic Review.

Authors:  Mary Clare Kennedy; Mohammad Karamouzian; Thomas Kerr
Journal:  Curr HIV/AIDS Rep       Date:  2017-10       Impact factor: 5.071

3.  Race and distance effects on regular syringe exchange program use and injection risks: a geobehavioral analysis.

Authors:  Chyvette T Williams; David S Metzger
Journal:  Am J Public Health       Date:  2010-04-15       Impact factor: 9.308

4.  Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire.

Authors:  Carla J Rash; Nancy M Petry; Kimberly C Kirby; Steve Martino; John Roll; Maxine L Stitzer
Journal:  Drug Alcohol Depend       Date:  2011-09-16       Impact factor: 4.492

5.  Overdose Prevention Site Acceptability among Residents and Businesses Surrounding a Proposed Site in Philadelphia, USA.

Authors:  Alexis M Roth; Alex H Kral; Allison Mitchell; Rohit Mukherjee; Peter Davidson; Stephen E Lankenau
Journal:  J Urban Health       Date:  2019-06       Impact factor: 3.671

6.  Drug use in business bathrooms: An exploratory study of manager encounters in New York City.

Authors:  Brett Wolfson-Stofko; Alex S Bennett; Luther Elliott; Ric Curtis
Journal:  Int J Drug Policy       Date:  2016-10-18

7.  Health impacts of a scale-up of supervised injection services in a Canadian setting: an interrupted time series analysis.

Authors:  Mary Clare Kennedy; Kanna Hayashi; M-J Milloy; Miranda Compton; Thomas Kerr
Journal:  Addiction       Date:  2021-12-02       Impact factor: 6.526

8.  Implementation and sustainability of safe consumption sites: a qualitative systematic review and thematic synthesis.

Authors:  Grace H Yoon; Timothy W Levengood; Melissa J Davoust; Shannon N Ogden; Alex H Kral; Sean R Cahill; Angela R Bazzi
Journal:  Harm Reduct J       Date:  2022-07-05

9.  Perspectives on supervised injection facilities among service industry employees in New York City: A qualitative exploration.

Authors:  Brett Wolfson-Stofko; Luther Elliott; Alex S Bennett; Ric Curtis; Marya Gwadz
Journal:  Int J Drug Policy       Date:  2018-10-22

Review 10.  The role of safer injection facilities in the response to HIV/AIDS among injection drug users.

Authors:  Thomas Kerr; Jo Kimber; Kora Debeck; Evan Wood
Journal:  Curr HIV/AIDS Rep       Date:  2007-12       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.